Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti‐inflammatory capacity in a cellular model of Alzheimer's disease
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2018.01.046
Abstract: &NA; Sulforaphane was reported to exert neuroprotective effects via upregulating expression of nuclear factor erythroid 2‐related factor 2 (Nrf2) and has received increasing attention as an alternative candidate for treatment of Alzheimer's disease (AD). However,… read more here.
Keywords: alzheimer disease; cellular model; bgr decrease; decrease ... See more keywords